Your prediction
Novozymes A/S B Stock
We can see a decrease in the price for Novozymes A/S B. Compared to yesterday it has lost -€0.960 (-1.840%).
Our community identified positive and negative aspects for Novozymes A/S B stock for the coming years. 1 users see the criterium "Return on equity" as a plus for the Novozymes A/S B stock. On the other hand our users think that "Revenue growth" could be a problem in the future.
Pros and Cons of Novozymes A/S B in the next few years
Pros
?
M***** P*******
?
B****
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Novozymes A/S B vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Novozymes A/S B | -1.840% | -2.652% | -4.437% | -2.434% | -4.821% | 10.658% | 0.269% |
| Solvay S.A. A | -1.180% | -3.546% | 5.508% | -12.988% | -0.439% | -75.362% | -72.425% |
| FMC Corp. | -1.650% | 2.647% | -8.917% | -66.074% | 6.114% | -89.783% | -85.642% |
| Covestro AG | -0.330% | -0.328% | -0.033% | 3.407% | 0.864% | 47.330% | 1.573% |
